As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction.

Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism.

Livercancer is a type of malignant hepatic tumor in or on the liver, which may cause due to excessive alcohol intake, diabetes, certain inherited liver diseases, and hepatitis.

There are three types of Neurofibromatosis; Neurofibromatosis type 1, Neurofibromatosis type 2, and Schwannomatosis.

The anxiety and depression are known to be the most common forms of psychiatric disorders from which a large population is affected across the globe.

A comparative analysis of the needs of different stakeholders (drug developers, diagnostic developers

Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.

The projected future opportunity is expected to be distributed across different application areas, types of analytical techniques used and various global regions

A discussion on various steps involved in development operations of companion diagnostics

An analysis of the big biopharma players engaged in this domain, featuring a heat map based on various parameters

Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.

The pipeline features drug candidates that target a wide range of biological antigens based on different antibody formats through novel mechanisms of action; more than 50% of these act by retargeting or activation of T-Cells

An analysis of the initiatives of big biopharma players engaged in this domain.

Development of therapies derived from cannabis and its components has been increasing in the recent past.

An analysis of the various partnerships pertaining to non-invasive cancer diagnostics

The financial opportunity within the liquid biopsy and other non-invasive cancer diagnostics market has been analyzed across

Presently, nearly 300 non-invasive diagnostic tests, designed for the detection of various types of cancers, are either already available in the market or under development across the world

An analysis of the various partnerships pertaining to non-invasive cancer diagnostics, which have been established between 2016 and 2019.

A detailed discussion on the cost implications across various steps of the HFE and usability testing process.

Human factors engineering and usability testing have now become an essential part of product design across almost all industries

Players involved in this domain are steadily expanding their capabilities in order to enhance their respective service portfolios and gain an advantage over competitor firms

Based on the revenues generated from different services for usability testing, currently, the maximum share is expected to be generated through evaluative testing methodologies (61%), followed by generative testing methodologies (39%).

Interferons are a family of naturally occurring proteins that are produced by eukaryotic cells and mostly show action against viral infections and other biological inducers.

A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes

In order to meet the growing demand for their services, Chinese CMOs are actively consolidating / expanding their capabilities through partnerships and / or dedicated expansion initiatives

Big pharma players have also made significant investments in this region, including establishing new facilities, expanding existing R&D centers and growing manufacturing facilities, focused on biotherapeutics

An analysis of the initiatives of big biopharma players engaged in this domain.

A discussion on the upcoming opportunities (such as development of companion diagnostics, emerging technologies for biomarker assessment, and others) that are likely to impact the evolution of this market over the coming years

Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.

Several novel biomarkers are presently under investigation for a variety of cancer indications; the initiatives of big pharmaceutical companies are indicative of the growing interest in this domain

A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies.

An analysis of the investments made, including seed financing, venture capital financing

Several therapy candidates are being investigated both as monotherapies and in combination

Presently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration

An in-depth analysis of the various patents that have been filed / granted related to neoantigens.

n fact, more than 6,000 patents were filed / granted related to neoantigen targeted therapies, since 1978.

 A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing regulatory affairs management services to medical device developers

More than 130 medical devices were approved by the FDA since January 2018

Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition.

The market landscape is highly fragmented, featuring the presence of both established players and new entrants; majority of such firms are located in the developed geographies

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Healthcare Analytics Market is expected to foresee significant growth during the forecast. North America to witness the highest growth

Despite mammalian cell cultures being the preferred manufacturing approach for biologics

Smart pills can be used to monitor drug adherence, temperature and some other parameters in patients. These pills are ingestible medical devices that can be taken orally to examine the gastrointestinal tract (GI).

A detailed review of the overall landscape of companies offering in silico drug discovery services for large molecules

Presently, in silico tools / approaches are available for the identification

Majority of the companies offer structure-based drug design focused on early stage drug discovery of a range of large molecules, including antibodies, proteins and peptides

A detailed assessment of the current market landscape of companies offering in silico drug discovery services for large molecules.

A detailed brand positioning analysis of key industry players, highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects

Over 150 software solutions are currently available for use in drug discovery